Dennis Eisenberg, MD
Obstetrics & Gynecology · Plano, TXNPI 1851382154
Payments from drug & device makers
Across 63 payments — averaging $174.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Applied Medical Resources Corporation$696
- AbbVie$531
- Astellas Pharma US Inc$245
- Gynesonics, Inc.$172
- Ascend Therapeutics US, LLC$132
- plus $319 from 10 others
What the payments were for
- Travel & lodging$1,92818%
- Food & beverage$2,55723%
- Education$6,50759%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $8,901 |
| Applied Medical Resources Corporation | 3 | $696 |
| AbbVie(2 entities) | 15 | $531 |
| Astellas Pharma US Inc | 2 | $245 |
| Gynesonics, Inc. | 1 | $172 |
| Ascend Therapeutics US, LLC | 10 | $132 |
| Atricure, Inc. | 2 | $87 |
| Pfizer | 4 | $63 |
| Minerva Surgical, Inc | 2 | $37 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Avion Pharmaceuticals | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Duchesnay USA Incorporated | 1 | $15 |
| Lupin Inc. | 1 | $15 |
| Exeltis, USA Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,997 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 128 | $11,346 |
| YuvafemEstradiol | 37 | $5,032 |
| ProgesteroneProgesterone, Micronized | 46 | $1,566 |
| ValacyclovirValacyclovir Hcl | 12 | $817 |
| Estradiol (Once Weekly)Estradiol | 14 | $786 |
| Ibandronate Sodium | 18 | $703 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $643 |
| Clobetasol Propionate | 15 | $214 |
| Alendronate Sodium | 13 | $214 |
| Fluconazole | 37 | $136 |
| Alprazolam | 13 | $99 |
| Fluoxetine Hcl | 15 | $52 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Plano
- John Paul RobertsPlano$4.9M
- Phyllis GeePlano$432K
- Elizabeth CoronadoPlano$155K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.